American Association of Neuromuscular & Electrodiagnostic Medicine

View all recommendations from this society

July 31, 2017

Don’t use intravenous immunoglobulin (IVIG) in the treatment of idiopathic length dependent axonal polyneuropathy.

IVIG is an expensive therapy with side effects that may include severe allergic reactions, headaches and blood clots. It is recommended for use in Guillain-Barre Syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy, but not other polyneuropathies.

These items are provided solely for informational purposes and are not intended as a substitute for consultation with a medical professional. Patients with any specific questions about the items on this list or their individual situation should consult their physician.

How The List Was Created

The Professional Practice Committee (PPC) of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) developed this list of recommendations. The PPC includes both neurologists and physical medicine and rehabilitation (PMR) physicians who come from varying practice settings and also includes the AANEM’s representatives to the American Medical Association (AMA) Current Procedural Terminology Panel and Relative Value Update Committee. The PPC members identified areas to be included on this list based on the greatest potential for overuse/misuse, quality improvement and availability of strong evidence-based research/support in the literature. The committee’s recommendations were discussed at an AANEM Board meeting that included chairs from AANEM committees. The PPC reviewed the feedback from this group and voted on the final Top Ten recommendations. These were then approved by the AANEM Board of Directors.

AANEM’s disclosure and conflict of interest policy can be found at


Patwa et al. Neurology. 2012 Mar 27;78(13): 1009-15.

Feasby et al. Transfus Med Rev. 2007 Apr;21(2 Supp 1): S57-107.

Donofrio PD et al. Muscle Nerve. 2009 Nov;40(5):890-900. doi: 10.1002/mus.21433.